NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

What's new with vitamin D

Posted: May 28, 2015.
Category - Medicines Update
Tagged with - Osteoporosis

New high dose preparations Several new high dose colecalciferol (vitamin D) preparations have recently been licensed in the UK, including:• Aviticol® 20,000 unit capsule• Fultium® D3 20,000 unit...

Read More...

Medicines Update Primary Care May 2015

Posted: May 21, 2015.
Category - Medicines Update Primary Care
Tagged with - Unlicensed Medicines Palliative Care

To view this bulletin in PDF format please click here

This bulletin contains information on:

  • Subcutaneous Fluids
  • Covert Medication
  • SPC's

Read More...

New WOSCAN protocols (May 2015)

Posted: May 21, 2015.
Category - Medicines Update Oncology

The following West of Scotland Cancer Network (WOSCAN) protocols are now available on the WOSCAN intranet site

Read More...

Drug Safety Update: Pomalidomide

Posted: May 21, 2015.
Category - Medicines Update Oncology

The Medicines Healthcare and Regulatory Agency (MHRA) have published new safety information relating to risks of cardiac failure, interstitial lung disease and hepatotoxicity with pomalidomide.  For full information

Read More...

Community Pharmacy Update April 2015

Posted: May 20, 2015.
Category - Medicines Update Community Pharmacy

The latest edition is available here. It has information on: Special Prescriptions Bowel Cancer Codeine fo...

Read More...

Amiodarone and dronedarone: monitoring

Posted: May 15, 2015.
Category - Medicines Update
Tagged with - Dronedarone

Amiodarone is an effective anti-arrhythmic, but it is associated with significant adverse effects: thyroid toxicity, hepatotoxicity and pulmonary toxicity. SIGN have provided clear guidance on amiodarone use and monitoring to minimise drug rela...

Read More...

Novel psychoactive substances: acute and chronic harms

Posted: May 15, 2015.
Category - Medicines Update

Novel Psychoactive Treatment UK Network (NEPTUNE) was developed to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances. It is aimed at clinicians working in a range of fron...

Read More...

Hydroxyzine and heart rhythm abnormalities

Posted: May 15, 2015.
Category - Medicines Update
Tagged with - MHRA Drug Safety Update

The MHRA have updated prescribing advice for this antihistamine following concerns of heart rhythm abnormalities. A European review concluded that hydroxyzine is associated with a small risk of QT interval prolongation and Torsade de Pointes. S...

Read More...

Temazepam prescribing change 01/06/15

Posted: May 15, 2015.
Category - Medicines Update
Tagged with - Benzodiazepines Formulary Prescribing

For many years, temazepam has been in the anomalous position where although a schedule 3 Controlled Drug (CD), it has been exempt from the prescription writing requirements that apply to all other schedule 2 and 3 CDs. The Home Office has recen...

Read More...

New WOSCAN protocols (April 2015)

Posted: May 14, 2015.
Category - Medicines Update Oncology

New WOSCAN protocols available.

Read More...